News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
661,492 Results
Type
Article (54891)
Company Profile (685)
Press Release (605916)
Section
Business (185140)
Career Advice (2552)
Deals (33485)
Drug Delivery (86)
Drug Development (74806)
Employer Resources (130)
FDA (15863)
Job Trends (15591)
News (317661)
Policy (30987)
Tag
Academia (2775)
Alliances (44749)
Alzheimer's disease (1256)
Approvals (15801)
Artificial intelligence (131)
Bankruptcy (278)
Best Places to Work (12200)
Biotechnology (476)
Breast cancer (121)
Cancer (1101)
Cardiovascular disease (93)
Career advice (2108)
Cell therapy (246)
Clinical research (59210)
Collaboration (395)
Compensation (202)
COVID-19 (2359)
C-suite (100)
Data (1146)
Diabetes (139)
Diagnostics (6435)
Earnings (71695)
Employer resources (114)
Events (108307)
Executive appointments (327)
FDA (16419)
Funding (367)
Gene therapy (177)
GLP-1 (544)
Government (4201)
Healthcare (20146)
Infectious disease (2438)
Inflammatory bowel disease (114)
Interviews (434)
IPO (16508)
Job creations (3834)
Job search strategy (1842)
Layoffs (392)
Legal (6872)
Lung cancer (170)
Manufacturing (182)
Medical device (14026)
Medtech (14030)
Mergers & acquisitions (17133)
Metabolic disorders (373)
Neuroscience (1536)
NextGen Class of 2024 (7305)
Non-profit (4942)
Northern California (1505)
Obesity (200)
Opinion (218)
Patents (97)
People (54130)
Pharmaceutical (133)
Phase I (18291)
Phase II (25757)
Phase III (20021)
Pipeline (451)
Postmarket research (2475)
Preclinical (7977)
Radiopharmaceuticals (254)
Rare diseases (215)
Real estate (6308)
Regulatory (21216)
Research institute (2512)
Resumes & cover letters (414)
Southern California (1329)
Startups (3479)
United States (14244)
Vaccines (491)
Weight loss (146)
Date
Today (84)
Last 7 days (691)
Last 30 days (3845)
Last 365 days (37096)
2024 (34058)
2023 (41387)
2022 (51564)
2021 (56187)
2020 (55978)
2019 (49800)
2018 (37213)
2017 (31876)
2016 (30598)
2015 (35988)
2014 (28825)
2013 (28474)
2012 (24993)
2011 (25254)
2010 (23711)
Location
Africa (838)
Arizona (135)
Asia (38692)
Australia (6951)
California (3458)
Canada (1287)
China (253)
Colorado (152)
Connecticut (172)
Europe (88227)
Florida (471)
Georgia (125)
Illinois (363)
Indiana (210)
Kansas (98)
Maryland (619)
Massachusetts (2818)
Michigan (176)
Minnesota (298)
New Jersey (994)
New York (989)
North Carolina (831)
Northern California (1505)
Ohio (148)
Pennsylvania (865)
South America (1157)
Southern California (1329)
Texas (490)
Washington State (401)
661,492 Results for "new wave surgical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Huntington’s disease
Takeda Walks Away From Wave Huntington’s Partnership After Sinking $260M in Collaboration
Wave Life Sciences in a Tuesday filing with the SEC said Takeda has elected to terminate its option to continue work on Wave’s WVE-003 clinical-stage Huntington’s disease program—a potential $5 billion commercial opportunity, according to the biotech.
October 16, 2024
·
3 min read
·
Tristan Manalac
Press Releases
New Wave Endo Has Been Recognized on the 2024 Inc. 5000 List of Fastest-Growing Companies and Was the #1 Fastest-Growing Surgical Device Company
August 28, 2024
·
2 min read
Alzheimer’s
Leqembi, Kisunla and Beyond: The Next Wave of Alzheimer’s at CTAD 2024
With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s Disease conference focused on the role these drugs might play, as well as combination therapies and innovative new treatment options.
November 11, 2024
·
6 min read
·
Kate Goodwin
Press Releases
Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs
October 31, 2024
·
9 min read
Press Releases
Wave Life Sciences to Present at Jefferies London Healthcare Conference
November 15, 2024
·
1 min read
Alzheimer’s disease
New Wave of Alzheimer’s Therapies Actively Engage the Immune System
Active immune therapies hold promise for preventing or slowing disease onset, but some experts warn of potential safety risks.
August 5, 2024
·
5 min read
·
Gail Dutton
Opinion
New Therapies Are Set to Upend the Alpha-1 Antitrypsin Deficiency Treatment Space
Vertex may have pivoted away from the space, but candidates in development by Arrowhead/Takeda, Wave, Korro and others could address the damage underlying alpha-1 antitrypsin deficiency and make today’s treatments a thing of the past.
October 28, 2024
·
3 min read
·
Jia Jie Chen
Press Releases
Johnson & Johnson Completes Acquisition of V-Wave
October 9, 2024
·
5 min read
Genetown
Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare Conference
Wave Life Sciences Ltd. (Nasdaq: WVE) today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in an analyst-led fireside chat at the 2024 RBC Capital Markets Global Healthcare Conference in New York City on Tuesday, May 14, 2024, at 8:30 a.m. ET.
May 7, 2024
·
1 min read
First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024
First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”) today announced that James Sapirstein, Chairman and CEO of First Wave BioPharma, will present at the BIO CEO & Investor Conference, which is planned for February 26-27, 2024, at the Marriott Marquis in New York City.
February 13, 2024
·
4 min read
1 of 66,150
Next
